RGEN Competitors
Repligen Corporation
$175.42
+$2.91(+1.69%)
50
Overall
40
Value
58
Tech
52
Quality
Market Cap
$8.44B
Volume
1.26M
52W Range
$100.99 - $198.87
Target Price
$193.15
RGEN competitors: NVAX, BMRN, NBIX, GE, CRL. Repligen Corporation is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
RGEN Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| NVAX Novavax, Inc. | $12.84 | $2.09B | $-0.48 | - | 66 |
| BMRN BioMarin Pharmaceutical Inc. | $54.55 | $10.72B | $4.10 | - | 45 |
| NBIX Neurocrine Biosciences, Inc. | $136.21 | $14.37B | $7.26 | - | 53 |
| GE GE Aerospace | $308.84 | $320.23B | $7.91 | 0.42% | 37 |
| CRL Charles River Laboratories International, Inc. | $299.02 | $14.41B | $11.36 | - | 60 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RGEN | $175.42 | +1.7% | 1.26M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |